Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07112950

Press Needle Acupuncture for Pain and Quality of Life in Lung Cancer Patients

The purpose of this clinical trial is to evaluate the effect of press needle acupuncture on pain management and quality of life improvement in patients with lung cancer.

The main question this study aims to answer is:

Does press needle acupuncture, when combined with standard therapy, provide better pain relief and quality of life improvement in lung cancer patients compared to standard therapy alone?

Researchers will compare press needle acupuncture to sham acupuncture to determine whether press needle acupuncture is more effective in reducing pain and improving quality of life.

Participants will:

Receive either press needle acupuncture or sham press needle acupuncture for 7 days

Visit the clinic once a week for examination and evaluation

Record improvements in pain intensity in a pain diary and assess quality of life using a quality of life questionnaire

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Lung Cancer Patients

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a confirmed diagnosis of lung cancer through histopathology or radiology.
  • Lung cancer patients aged over 18 years.
  • Stage III-IV lung cancer patients receiving therapy at Dr. Cipto Mangunkusumo National General Hospital (RSUPN) and Tangerang District General Hospital (RSUD Kabupaten Tangerang).
  • Patients with a VAS score >10 mm for baseline pain and >40 mm during breakthrough pain.
  • Willing to participate in the study until completion by signing the informed consent form.

Exclusion criteria

  • Lung cancer patients with deteriorating general condition.
  • Presence of wounds or infections at the press needle insertion site.
  • History of allergy to stainless steel materials.
  • Patients with blood clotting disorders: platelet count <50,000/μL, ANC <1000/mm³, or patients undergoing anticoagulant therapy with INR >2.142.

Treatment and study plan

Press Needle Acupuncture and standart therapy

Device

The patient will have a press needle applied, which will be removed on the seventh day.

Primary outcomes

  1. Visual Analogue Scale (VAS) for Pain

    Time frame: Before therapy, Day 1, Day 3, Day 7, and Day 14

    Pain intensity will be measured using the Visual Analogue Scale (VAS), which consists of a horizontal or vertical line 10 cm (100 mm) in length, representing a continuum of pain intensity from:

    0 = No pain at all

    10 = Worst imaginable pain

Secondary outcomes

  1. Functional Assessment of Cancer Therapy - Lung (FACT-L)

    Time frame: Before therapy, Day 7, and Day 14

    Quality of life will be assessed using the FACT-L questionnaire, consisting of 37 items rated on a 0-4 Likert scale:

    0 = Not at all

    • = A little bit
    • = Somewhat
    • = Quite a bit
    • = Very much

    Total scores range from 0 to 28 (higher scores indicate better quality of life).

Study contacts

Contact information is provided by the study sponsor or research team.

Yuanti Yunus Konda, MD

CONTACT

[email protected]

+6285240864987

Sponsors and collaborators

Lead sponsor

Indonesia University

Other

Registry information

Official study title

The Effect of Press Needle Acupuncture on Pain Reduction and Quality of Life Improvement in Lung Cancer Patients

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 8, 2025
Registry last updated
Aug 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.